Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis

1 Nov 2006

Abstract excerpt

BACKGROUND: Multiple sclerosis (MS) is a continuously disabling disease and it is unresponsive to high dose steroid and immunomodulation with disease progression. The autologous haematopoietic stem cell transplantation (ASCT) has been introduced in the treatment of refractory forms of multiple sclerosis. In this study, the clinical outcomes followed by ASCT were evaluated for patients with progressive MS....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Multiple Sclerosis Research Studies
Share to Polyomavirus and related diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17134581
DOI: 10.1097/00029330-200611020-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosisPMID 17134581Read ↗

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisSemantic proximity Read ↗

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.Semantic proximity Read ↗

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantationSemantic proximity Read ↗

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple SclerosisSemantic proximity Read ↗

Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosisSemantic proximity Read ↗

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell TransplantSemantic proximity Read ↗

Neural Stem Cells Derived From Primitive Mesenchymal Stem Cells Reversed Disease Symptoms and Promoted Neurogenesis in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple SclerosisSemantic proximity Read ↗

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple SclerosisSemantic proximity Read ↗

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.Semantic proximity Read ↗

The effects of culture-expanded, non-cryopreserved adipose tissue mesenchymal stem cells (AT-MSCs) on neurological and immunological paradigms in females with secondary progressive multiple sclerosis: a phase I/II clinical trialSemantic proximity Read ↗

Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosisSemantic proximity Read ↗

NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDPSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.